KOSDAQ · Healthcare · ₩54B
₩1,305-2.25%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 1.6% · as of 26.10.27
Among 37 신약 개발 peers
Quarterly Revenue Growth
“매출은 커졌지만 돈 버는 구조는 아직 다듬는 중이에요.”
In the company's words · 2026 2분기 filing